$FLR

FLUOR CORP

1
0
0

No SEC Form 4 filings for $FLR in the last 30 days.

Med

Fluor Is Down 26%. Is It Finally Time to Buy?

Fluor (FLR) shares are down about 26% after falling following its Q1 2026 earnings, according to the article. The company reported $15.5B total revenue in 2025 and has a $25.7B backlog. Fluor sold down its NuScale Power stake for about $2.4B, boosting cash to $3.2B, and analysts expect ~15% annual earnings growth over 3–5 years.

Fast-paced Momentum Stock Fluor (FLR) Is Still Trading at a Bargain

Fluor (FLR) is highlighted as a compelling investment for those seeking momentum stocks still trading at reasonable prices. The article emphasizes FLR's recent price performance, high beta, and a Zacks Rank #1 (Strong Buy), indicating strong momentum. Despite these growth indicators, FLR is noted for its attractive valuation, evidenced by a low Price-to-Sales ratio of 0.44.

North Texas’ Fluor Opens Office in Romania to Advance Next‑Gen Nuclear Energy Projects

Irving-based Fluor Corporation has opened a new European office in Bucharest, Romania, to strengthen its commitment to advancing nuclear energy projects in the region. This expansion supports Romania's goals for clean, reliable power and builds on Fluor's existing contributions to the country's nuclear development, including the SMR project in Doicești and the Cernavodă nuclear power plant expansion. The new office will serve as a hub for talent and execution capabilities, leveraging Bucharest's strategic advantages and skilled workforce.

News on $FLR